Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer

Breast Cancer Research and Treatment

Volumn 141, Issue 3, 2013, Pages 375-384

  Covington, Kyle R ^a   Brusco, Lauren ^a   Barone, Ines ^b   Tsimelzon, Anna ^a   Selever, Jennifer ^a   Corona Rodriguez, Arnoldo ^a   Brown, Powel ^c   Kumar, Rakesh ^d   Hilsenbeck, Susan G ^a   Fuqua, Suzanne A W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALABRIA   (Italy)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Breast cancer; Cytoskeleton; Metastasis; MTA2; Rho

Indexed keywords

PROTEIN MTA2; RHO FACTOR; RHO KINASE INHIBITOR; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CELL ADHESION; CELL GROWTH; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; COLONY FORMATION; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; MTA2 GENE; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR GENE; VECTOR CONTROL;

EID: 84887056650     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2709-5     Document Type: Article

References (50)

1. Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 50(19):6130-6138
2. Stafford LJ, Vaidya KS, Welch DR (2008) Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 40(5):874-891. doi: 10.1016/j.biocel.2007.12.016
3. Burbelo P, Wellstein A, Pestell RG (2004) Altered Rho GTPase signaling pathways in breast cancer cells. Breast Cancer Res Treat 84(1):43-48. doi: 10.1023/B:BREA.0000018422.02237.f9
4. Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R et al (2005) RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev 19(17):1974-1979. doi: 10.1101/gad.1310805
5. Keely PJ (2001) Ras and Rho protein induction of motility and invasion in T47D breast adenocarcinoma cells. Methods Enzymol 333:256-266
6. Tang Y, Olufemi L, Wang MT, Nie D (2008) Role of Rho GTPases in breast cancer. Front Biosci 13:759-776
7. Kumar R, Wang RA, Bagheri-Yarmand R (2003) Emerging roles of MTA family members in human cancers. Semin Oncol 30(5 Suppl 16):30-37
8. Nicolson GL, Nawa A, Toh Y, Taniguchi S, Nishimori K, Moustafa A (2003) Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis 20(1):19-24
9. Singh RR, Kumar R (2007) MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer. J Mammary Gland Biol Neoplasia 12(2-3):115-125. doi: 10.1007/s10911-007-9043-7
10. Toh Y, Nicolson GL (2009) The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis 26(3):215-227. doi: 10.1007/s10585-008-9233-8
11. Zhang H, Stephens LC, Kumar R (2006) Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Clin Cancer Res 12(5):1479-1486. doi: 10.1158/1078-0432.CCR-05-1519
12. Cui Y, Niu A, Pestell R, Kumar R, Curran EM, Liu Y et al (2006) Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol 20(9):2020-2035. doi: 10.1210/me.2005-0063
13. Fu J, Qin L, He T, Qin J, Hong J, Wong J et al (2011) The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res 21(2):275-289. doi: 10.1038/cr.2010.118
14. Toh Y, Pencil SD, Nicolson GL (1995) Analysis of the complete sequence of the novel metastasis-associated candidate gene, MTA1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene 159(1):97-104
15. Toh Y, Pencil SD, Nicolson GL (1994) A novel candidate metastasis-associated gene, MTA1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269(37):22958-22963
16. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA (2003) MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113(2):207-219
17. Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington KR et al (2011) Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α. J Natl Cancer Inst 103(7):538-552. doi: 10.1093/jnci/djr058
18. Girish V, Vijayalakshmi A (2004) Affordable image analysis using NIH Image/ImageJ. Indian J Cancer 41(1):47
19. Barone I, Iacopetta D, Covington KR, Cui Y, Tsimelzon A, Beyer A et al (2010) Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity. Oncogene 29(16):2404-2414. doi: 10.1038/onc.2009.520
20. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D et al (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6(1):1-6
21. Smyth GK (2005) Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and bioconductor. Springer, New York, pp 397-420
22. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2):249-264. doi: 10.1093/biostatistics/4.2.249
23. Covington KR, Parikh A (2011) The Red-R framework for integrated discovery. Red-R J. http://code.google.com/p/r-orange/. Accessed 14 Dec 2011
24. Wang Y, Klijn JGM, Zhang Y, Sieuwerts AM, Look MP, Yang F et al (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365(9460):671-679. doi: 10.1016/S0140-6736(05) 17947-1
25. Sabatier R, Finetti P, Cervera N, Lambaudie E, Esterni B, Mamessier E et al (2011) A gene expression signature identifies two prognostic subgroups of basal breast cancer. Breast Cancer Res Treat 126(2):407-420. doi: 10.1007/s10549-010-0897-9
26. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C et al (2007) NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res 35(Database issue):D760-D765. doi: 10.1093/nar/gkl887
27. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4(5):P3
28. Therneau T, original Report by Thomas Lumley (2009) Survival: survival analysis, including penalised likelihood; R package version 2.35-8. http://CRAN.R-project.org/package=survival. Accessed 14 Dec 2011
29. R Development Core Team (2010) R: a language and environment for statistical computing. Vienna, Austria; 2010. ISBN 3-900051-07-0
30. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403-410
31. Bauer K, Parise C, Caggiano V (2010) Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer. BMC Cancer 10:228. doi: 10.1186/1471-2407-10-228
32. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T et al (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6):515-527. doi: 10.1016/j.ccr.2006.10.008
33. Kumar S, Weaver VM (2009) Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev 28(1-2):113-127. doi: 10.1007/s10555-008-9173-4
34. Evers EE, Zondag GC, Malliri A, Price LS, ten Klooster JP, van der Kammen RA et al (2000) Rho family proteins in cell adhesion and cell migration. Eur J Cancer 36(10):1269-1274 This paper indicates that Rho and rac are in balance and that rho is associated with fibroblast morphology
35. Yamazaki D, Kurisu S, Takenawa T (2005) Regulation of cancer cell motility through actin reorganization. Cancer Sci 96(7):379-386. doi: 10.1111/j.1349-7006.2005.00062.x
36. Narumiya S, Tanji M, Ishizaki T (2009) Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 28(1-2):65-76. doi: 10.1007/s10555-008-9170-7
37. Kedrin D, van Rheenen J, Hernandez L, Condeelis J, Segall JE (2007) Cell motility and cytoskeletal regulation in invasion and metastasis. J Mammary Gland Biol Neoplasia 12(2-3):143-152. doi: 10.1007/s10911-007-9046-4
38. Ying H, Biroc SL, Li WW, Alicke B, Xuan JA, Pagila R et al (2006) The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Mol Cancer Ther 5(9):2158-2164. doi: 10.1158/1535-7163.MCT-05-0440
39. Liu GJ, Wang ZJ, Wang YF, Xu LL, Wang XL, Liu Y et al (2012) Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur J Clin Pharmacol 68(2):131-139. doi: 10.1007/s00228-011-1100-x
40. Amano M, Nakayama M, Kaibuchi K (2010) Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken) 67(9):545-554. doi: 10.1002/cm.20472
41. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI et al (2003) Staging system for breast cancer: revisions for the 6th edition of the AJCC cancer staging manual. Surg Clin North Am 83(4):803-819
42. Henson DE, Ries L, Freedman LS, Carriaga M (1991) Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer 68(10):2142-2149
43. Egner JR (2010) AJCC cancer staging manual. JAMA 304(15):1726
44. Price JE, Polyzos A, Zhang RD, Daniels LM (1990) Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50(3):717-721
45. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL et al (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10(6):529-541. doi: 10.1016/j.ccr.2006.10.009
46. Goss PE, Chambers AF (2010) Does tumour dormancy offer a therapeutic target? Nat Rev Cancer 10(12):871-877. doi: 10.1038/nrc2933
47. Park YJ, Ahn HJ, Chang HK, Kim JY, Huh KH, Kim MS et al (2009) The RhoGDI-alpha/JNK signaling pathway plays a significant role in mycophenolic acid-induced apoptosis in an insulin-secreting cell line. Cell Signal 21(2):356-364. doi: 10.1016/j.cellsig.2008.11.009
48. Linares A, Dalenc F, Balaguer P, Boulle N, Cavailles V (2011) Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies? J Biomed Biotechnol 2011:856985. doi: 10.1155/2011/856985
49. Ginestier C, Cervera N, Finetti P, Esteyries S, Esterni B, Adélaïde J et al (2006) Prognosis and gene expression profiling of 20q13-amplified breast cancers. Clin Cancer Res 12(15):4533-4544. doi: 10.1158/1078-0432.CCR-05-2339
50. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B et al (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13(11):3207-3214